No Picture
News

MedTech Innovator Selects 20 Startups for Annual Asia Pacific Accelerator and Announces Extended Asia Pacific Partnership With Johnson & Johnson

LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to… […]

No Picture
News

Peninsula biotech spins out parasite-fighting drugs to biotech legends’ startup

A Peninsula biotech company is supplying a set of parasite-fighting preclinical compounds to a startup created by one of the scientists who co-founded the company more than two decades ago.

Kainomyx Inc. — launched by a Stanford University-connected t… […]

No Picture
News

‘We’ve got to hammer that home’: Tony Fauci talks Covid-19 response, promise of therapies, vaccines

As Foster City-based Gilead Sciences moves forward with remdesivir and other Bay Area companies pursue new or repurposed drugs and vaccines against Covid-19 and the coronavirus that causes the disease, NIAID chief Dr. Tony Fauci talked in a webinar wit… […]

No Picture
News

89bio Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases,… […]

No Picture
News

Adverum Biotechnologies Announces First Patient Randomized in Phase 2 INFINITY Trial of ADVM-022 Single Injection Gene Therapy for Diabetic Macular Edema (DME)

— INFINITY trial is currently enrolling patients with DME, the most common cause of vision loss in people with diabetic retinopathy — REDWOOD CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-s… […]

No Picture
News

Calithera Biosciences Initiates Phase 1b Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis

SOUTH SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-thre… […]